Randomized, double-blind, placebo-controlled trial of fecal microbiota transplantation from young physically active donors to promote resilient aging: clinical trial protocol (ARMOR study)

Abstract Background Sarcopenia, characterized by the progressive loss of skeletal muscle mass and strength in older adults, is a key determinant of frailty and functional decline. Affecting up to 15% of individuals aged 65–80 years and more than 50% of those over 80, sarcopenia not only compromises...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Camila Astudillo-Guerrero, Ángel Garrido, Dominique Masferrer, Carlos Sepúlveda, Loreto Olavarría, Rosa Del Campo, Roberto Bravo-Sagua, Francisco Javier Cubero, Felipe Salech, Daniela Thumala-Dockendorff, Pamela J Urrutia, Rodrigo Quera, Daniel Bunout, Ricardo Espinoza, Gonzalo Jorquera
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2026-02-01
Serie:	BMC Geriatrics
Soggetti:	Gut microbiome Aging Fecal microbiota transplantation Frailty Functional autonomy
Accesso online:	https://doi.org/10.1186/s12877-025-06920-7
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!